Osteoporosis: assessment for diagnosis, evaluation and treatment

Looker, 1997, Prevalence of low femoral bone density in older U.S. adults from NHANES III, J. Bone Miner. Res., 12, 1761, 10.1359/jbmr.1997.12.11.1761 Melton, 2000, Effects of body size and skeletal site on the estimated prevalence of osteoporosis in women and men, Osteoporos Int., 11, 977, 10.1007/s001980070037 van Staa, 2001, Epidemiology of fractures in England and Wales, Bone, 29, 517, 10.1016/S8756-3282(01)00614-7 Cummings, 2002, Epidemiology and outcomes of osteoporotic fractures, Lancet, 359, 1761, 10.1016/S0140-6736(02)08657-9 Johnell, 2004, An estimate of the worldwide prevalence, mortality and disability associated with hip fracture, Osteoporos Int., 15, 10.1007/s00198-004-1627-0 NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. J Am Med Assoc 2001;285:785–95. National Osteoporosis Foundation Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Osteoporos Int 1998;8 (Suppl 4):S1–80. Kanis, 2002, Diagnosis of osteoporosis and assessment of fracture risk, Lancet, 359, 1929, 10.1016/S0140-6736(02)08761-5 Siris, 2001, Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment, J Am Med Assoc, 286, 2815, 10.1001/jama.286.22.2815 Cummings, 2002, Clinical use of bone densitometry: scientific review, J Am Med Assoc, 288, 1889, 10.1001/jama.288.15.1889 Gonnelli, 2002, Heel ultrasonography in monitoring alendronate therapy: a four-year longitudinal study, Osteoporos Int., 13, 415, 10.1007/s001980200048 Drake, 2002, Use of phalangeal bone mineral density and multi-site speed of sound conduction to monitor therapy with alendronate in postmenopausal women, Osteoporos Int., 13, 249, 10.1007/s001980200022 Melton, 2001, Does bone density predict fractures comparably in men and women?, Osteoporos Int., 12, 707, 10.1007/s001980170044 1998 National Osteoporosis Foundation. Physician’s guide to prevention and treatment of osteoporosis. Belle Mead. NJ: Excerpta Medica Inc. Bauer, 1993, Factors associated with appendicular bone mass in older women. The Study Of Osteoporotic Fractures Research Group, Ann. Intern. Med., 118, 657, 10.7326/0003-4819-118-9-199305010-00001 Dargent-Molina, 1996, Fall-related factors and risk of hip fracture: the EPIDOS prospective study, Lancet, 348, 145, 10.1016/S0140-6736(96)01440-7 Cummings, 1995, Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group, N. Engl. J. Med., 332, 767, 10.1056/NEJM199503233321202 Johnell, 1995, Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study, J. Bone Miner. Res., 10, 1802, 10.1002/jbmr.5650101125 Lau, 2001, Risk factors for hip fracture in Asian men and women: the Asian osteoporosis study, J. Bone Miner. Res., 16, 572, 10.1359/jbmr.2001.16.3.572 Ribot, 1992, Assessment of the risk of post-menopausal osteoporosis using clinical factors, Clin. Endocrinol. (Oxford), 36, 225, 10.1111/j.1365-2265.1992.tb01436.x Lydick, 1998, Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density, Am. J. Manag. Care, 4, 37 Black, 1998, SOFSURF: a simple, useful risk factor system can identify the large majority of women with osteoporosis [Abstract], Bone, 23, S605 Cadarette, 2000, Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry, CMAJ, 162, 1289 Weinstein, 2000, Identification of at-risk women for osteoporosis screening, Am. J. Obstet. Gynecol., 183, 547, 10.1067/mob.2000.106594 Koh, 2001, A simple tool to identify Asian women at increased risk of osteoporosis, Osteoporos. Int., 12, 699, 10.1007/s001980170070 Sedrine, 2002, Development and assessment of the Osteoporosis Index of Risk (OSIRIS) to facilitate selection of women for bone densitometry, Gynecol. Endocrinol., 16, 245, 10.1080/713603052 Nguyen, 2004, Limited utility of clinical indices for the prediction of symptomatic fracture risk in postmenopausal women, Osteoporos. Int., 15, 49, 10.1007/s00198-003-1511-3 Cadarette, 2001, Evaluation of decision rules for referring women for bone densitometry by dual-energy X-ray absorptiometry, J. Am. Med. Assoc., 286, 57, 10.1001/jama.286.1.57 Geusens, 2002, Performance of risk indices for identifying low bone density in postmenopausal women, Mayo Clin. Proc., 77, 629, 10.4065/77.7.629 Richy, 2004, Validation and comparative evaluation of the osteoporosis self-assessment tool (OST) in a Caucasian population from Belgium, QJM, 97, 39, 10.1093/qjmed/hch002 Cadarette, 2004, The validity of decision rules for selecting women with primary osteoporosis for bone mineral density testing, Osteoporos. Int., 15, 361, 10.1007/s00198-003-1552-7 Kayan, 2003, Performance of clinical referral criteria for bone densitometry in patients under 65 years of age assessed by spine bone mineral density, Postgrad. Med. J., 79, 581, 10.1136/pmj.79.936.581 Ben Sedrine, 2002, Interest of a prescreening questionnaire to reduce the cost of bone densitometry, Osteoporos. Int., 13, 434, 10.1007/s001980200051 Olszynski, 2004, Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment, Clin. Ther., 26, 15, 10.1016/S0149-2918(04)90002-1 Lombardi, 2001, The assessment of bone mass in men, Calcif. Tissue Int., 69, 222, 10.1007/s00223-001-1057-3 Koh, 2002, Identifying osteoporosis in a cohort of Asian men using a simple tool which identifies osteoporosis in Asian women, Osteoporos. Int., 13, 120 Hochberg, 2002, Validation of a risk index to identify men with an increased likelihood of osteoporosis, J. Bone Miner. Res., 17, S231 Adler, 2003, Performance of the osteoporosis self-assessment screening tool for osteoporosis in American men, Mayo Clin. Proc., 78, 723, 10.4065/78.6.723 Crandall C. Laboratory workup for osteoporosis. Which tests are most cost-effective? Postgrad Med 2003;114:35–8, 41–4. Deutschmann, 2002, Search for occult secondary osteoporosis: impact of identified possible risk factors on bone mineral density, J. Intern. Med., 252, 389, 10.1046/j.1365-2796.2002.01040.x Johnson, 1989, Contributing diagnoses in osteoporosis. The value of a complete medical evaluation, Arch. Intern. Med., 149, 1069, 10.1001/archinte.1989.00390050061012 Tannenbaum, 2002, Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women, J. Clin. Endocrinol. Metab., 87, 4431, 10.1210/jc.2002-020275 Delmas, 2002, Treatment of postmenopausal osteoporosis, Lancet, 359, 2018, 10.1016/S0140-6736(02)08827-X Cauley, 2003, Effects of estrogen plus progestin on risk of fracture and bone mineral density: the women’s health initiative randomized trial, J. Am. Med. Assoc., 290, 1729, 10.1001/jama.290.13.1729 Kanis, 2003, Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the multiple outcomes of Raloxifene evaluation trial, Bone, 33, 293, 10.1016/S8756-3282(03)00200-X Hosking, 1998, Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group, N. Engl. J. Med., 338, 485, 10.1056/NEJM199802193380801 Pouilles, 1997, Effects of cyclical etidronate therapy on bone loss in early postmenopausal women who are not undergoing hormonal replacement therapy, Osteoporos. Int., 7, 213, 10.1007/BF01622291 Mortensen, 1998, Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up, J. Clin. Endocrinol. Metab., 83, 396, 10.1210/jc.83.2.396 Reginster, 1995, A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss, Am. J. Med., 98, 452, 10.1016/S0002-9343(99)80344-1 Feldstein, 2003, Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation, Arch. Intern. Med., 163, 2165, 10.1001/archinte.163.18.2165 Chevalley, 2002, An osteoporosis clinical pathway for the medical management of patients with low-trauma fracture, Osteoporos. Int., 13, 450, 10.1007/s001980200053 Wainwright, 2001, A large proportion of fractures in postmenopausal women occur with baseline bone mineral density T-score > −2.5, J. Bone Miner. Res., 16, 155 Black, 2001, An assessment tool for predicting fracture risk in postmenopausal women, Osteoporos. Int., 12, 519, 10.1007/s001980170072 Miller, 2004, An approach to identifying osteopenic women at increased short-term risk of fracture, Arch. Intern. Med., 164, 1113, 10.1001/archinte.164.10.1113 McClung, 2001, Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group, N. Engl. J. Med., 344, 333, 10.1056/NEJM200102013440503 Cranney, 2002, Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis, Endocr. Rev., 23, 570, 10.1210/er.2001-9002 Neer, 2001, Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis, N. Engl. J. Med., 344, 1434, 10.1056/NEJM200105103441904 Meunier, 2004, The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis, N. Engl. J. Med., 350, 459, 10.1056/NEJMoa022436 Brumsen, 2002, Daily oral pamidronate in women and men with osteoporosis: a 3-year randomized placebo-controlled clinical trial with a 2-year open extension, J. Bone Miner. Res., 17, 1057, 10.1359/jbmr.2002.17.6.1057 Dukas, 2004, Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of more than 500mg daily, J. Am. Geriatr. Soc., 52, 230, 10.1111/j.1532-5415.2004.52060.x Haguenauer, 2000, Fluoride for the treatment of postmenopausal osteoporotic fractures: a meta-analysis, Osteoporos. Int., 11, 727, 10.1007/s001980070051 Chapuy, 1992, Vitamin D3 and calcium to prevent hip fractures in the elderly women, N. Engl. J. Med., 327, 163, 10.1056/NEJM199212033272305 Lindsay, 1997, Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis, Lancet, 350, 550, 10.1016/S0140-6736(97)02342-8 Black, 2003, The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis, N. Engl. J. Med., 349, 1207, 10.1056/NEJMoa031975 Rittmaster, 2000, Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate, J. Clin. Endocrinol. Metab., 85, 2129, 10.1210/jc.85.6.2129 Finkelstein, 2003, The effects of parathyroid hormone, alendronate, or both in men with osteoporosis, N. Engl. J. Med., 349, 1216, 10.1056/NEJMoa035725